Prostaglandins as modulators of the autonomic nervous system.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 4359038)

Published in Fed Proc on January 01, 1974

Authors

M J Brody, P J Kadowitz

Articles citing this

Arachidonic acid and prostaglandin endoperoxide metabolism in isolated rabbit and coronary microvessels and isolated and cultivated coronary microvessel endothelial cells. J Clin Invest (1983) 1.23

Prostaglandin modulation of Ca2+ channels in rat sympathetic neurones is mediated by guanine nucleotide binding proteins. J Physiol (1992) 1.21

Modulation by neurotransmitters of catecholamine secretion from sympathetic ganglion neurons detected by amperometry. Proc Natl Acad Sci U S A (1997) 1.20

Prostaglandin and noradrenaline interactions in rat brain synaptosomes [proceedings]. Br J Pharmacol (1979) 1.09

Time-dependent effect of prostaglandin E2 inhalation on airway responses to bronchoconstrictor agents in normal subjects. Thorax (1982) 0.99

Role of inflammatory mediators in colonic smooth muscle function in ulcerative colitis. Dig Dis Sci (1988) 0.96

Prostaglandin release from cat and dog spleen. Br J Pharmacol (1975) 0.87

Effects of indomethacin on endocrine responses and nitrogen loss after surgery. Ann Surg (1987) 0.86

Effects of prostaglandin E2 and a prostaglandin endoperoxide analogue on neuroeffector transmission in the rat anococcygeus msucle. Br J Pharmacol (1978) 0.86

ACTH release induced in rats by noradrenaline is mediated by prostaglandin E2. J Physiol (1991) 0.83

Vasoconstrictor response to arachidonic acid in the isolated hind limb of the dog. Br J Pharmacol (1977) 0.83

Effect of propranolol on the airway response to prostaglandin E2 in normal man. Br J Clin Pharmacol (1981) 0.80

Nonadrenergic effects of isoproterenol in dogs with hypoxic pulmonary vasoconstriction. Possible role of prostaglandins. J Clin Invest (1983) 0.77

Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries. Br J Pharmacol (1988) 0.75

Increase in reflex vasoconstriction with indomethacin in patients with orthostatic hypotension and central nervous system involvement. Br Heart J (1984) 0.75

Prostaglandin F2alpha reduces the algesic effect of bradykinin by antagonizing the pain enhancing action of endogenously released prostaglandin E. Br J Pharmacol (1977) 0.75

Facilitation of sympathetic neurotransmission in the rat anococcygeus muscle by prostaglandins D2 and F2 alpha. Br J Pharmacol (1980) 0.75

Letter: Prostaglandins in depression. Br Med J (1976) 0.75

Articles by these authors

Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71

The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol (1985) 3.29

Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol (1981) 3.18

Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther (1981) 3.14

Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res (1979) 3.11

Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood (1981) 2.93

Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther (1986) 2.64

Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim Biophys Acta (1982) 2.00

Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther (1984) 1.85

Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol (1981) 1.74

Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun (2001) 1.74

Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmacol (1983) 1.68

In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation (2000) 1.55

Influence of acetylcholine on contractile force and cyclic nucleotide levels in the isolated perfused rat heart. J Pharmacol Exp Ther (1973) 1.48

Identification and specific blockade of two receptors for histamine in the cardiovascular system. J Pharmacol Exp Ther (1976) 1.47

Enhancement of renal blood flow by furosemide. J Pharmacol Exp Ther (1968) 1.34

Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide. J Pharmacol Exp Ther (1980) 1.31

Effects of several saluretic-diuretic agents on renal hemodynamics. J Pharmacol Exp Ther (1966) 1.27

Potentiation of adrenergic venomotor responses by angiotensin, prostaglandin F 2 and cocaine. J Pharmacol Exp Ther (1971) 1.26

Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. J Pharmacol Exp Ther (1984) 1.23

Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate. J Pharmacol Exp Ther (1985) 1.20

Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci U S A (1999) 1.16

A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol (2000) 1.16

Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension (1980) 1.15

Neurohumoral mediation of active reflex vasodilatation. Fed Proc (1967) 1.14

Evidence for a neurotransmitter role for epinephrine derived from the adrenal medulla. Am J Physiol (1982) 1.11

L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun (1993) 1.11

The influence of cognitive bias on the perceived odor, irritation and health symptoms from chemical exposure. Int Arch Occup Environ Health (1997) 1.10

Histamine, norepinephrine and serotonin content of nasal polyps. Laryngoscope (1979) 1.07

Hemodynamic mechanisms of erection in the canine penis. Am J Physiol (1967) 1.07

Arterial pressure development in neonatal and young spontaneously hypertensive rats. Blood Vessels (1977) 1.03

Perceived odor, irritation, and health symptoms following short-term exposure to acetone. Am J Ind Med (1997) 1.03

Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine. J Pharmacol Exp Ther (1986) 1.03

Prevention of the development of renal hypertension by anteroventral third ventricular tissue lesions. Circ Res (1977) 1.02

Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels. J Pharmacol Exp Ther (1975) 1.02

Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat. Circ Res (1979) 1.02

Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol (1986) 1.01

Atriopeptin II relaxes and elevates cGMP in bovine pulmonary artery but not vein. J Appl Physiol (1985) (1986) 1.01

Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.01

Distribution of vasodilator nerves in the canine hindlimb. Am J Physiol (1970) 1.01

Evidence that regulation of hepatic guanylate cyclase activity involves interactions between catalytic site -SH groups and both substrate and activator. Arch Biochem Biophys (1981) 1.01

Renal vascular effects of endoperoxide analogs, prostaglandins, and arachidonic acid. Am J Physiol (1977) 1.00

Role of sympathetic nerve activity in the generation of vascular nitric oxide in urethane-anesthetized rats. Hypertension (1991) 0.98

Differential effects of ibuprofen and indomethacin in the regional circulation of the dog. J Pharmacol Exp Ther (1981) 0.98

Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5. Drugs Exp Clin Res (2002) 0.98

Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses. Circ Res (1999) 0.97

The pharmacological effects of allicin, a constituent of garlic oil. Agents Actions (1988) 0.97

Prostaglandins and the lung. Am Rev Respir Dis (1978) 0.96

Methylene blue selectively inhibits pulmonary vasodilator responses in cats. J Appl Physiol (1985) (1989) 0.95

Physiological and pharmacological roles of prostaglandins. Annu Rev Pharmacol (1975) 0.95

Circulatory effects of hydrocortisone and protection against endotoxin shock in cats. Eur J Pharmacol (1970) 0.95

Differential effects of prostaglandins E 1 , E 2 , F 1 and F 2 on adrenergic vasoconstriction in the dog hindpaw. J Pharmacol Exp Ther (1971) 0.95

Effects of prostaglandins E1 and F2a on the swine pulmonary circulation. Proc Soc Exp Biol Med (1974) 0.95

Evidence for non-mast cell histamine in the vascular wall. Blood Vessels (1975) 0.94

Neurogenic and humoral factors controlling vascular resistance in the spontaneously hypertensive rat. Circ Res (1974) 0.94

Bronchoactive metabolites of arachidonic acid and their role in airway function. Prostaglandins (1981) 0.93

Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol (1993) 0.93

Differential effects of rat endothelin on regional blood flow in the cat. Eur J Pharmacol (1989) 0.93

Influence of a prostaglandin endoperoxide analogue on the canine pulmonary vascular bed. Circ Res (1977) 0.93

Effects of porcine and rat endothelin and an analog on blood pressure in the anesthetized cat. Eur J Pharmacol (1989) 0.93

A novel right-heart catheterization technique for in vivo measurement of vascular responses in lungs of intact mice. Am J Physiol Heart Circ Physiol (2000) 0.93

Factors influencing the altered pain perception in the spontaneously hypertensive rat. Brain Res (1982) 0.92

N omega-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. J Appl Physiol (1985) (1991) 0.92

Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease. Andrology (2014) 0.92

Vasopressin and vascular reactivity in the development of DOCA hypertension in rats with hereditary diabetes insipidus. Hypertension (1982) 0.91

Differential effects of prostaglandins in the mesenteric vascular bed. Am J Physiol (1978) 0.91

Cerebral vascular responses to physiological stimulation of sympathetic pathways in cats. Circ Res (1979) 0.91

Interruption of the maintenance phase of established hypertension by ablation of the anteroventral third ventricle (AV3V) in rats. Clin Exp Hypertens (1980) 0.90

Vasopressin-central nervous system interactions in the development of DOCA hypertension. Hypertension (1982) 0.90

Actions of prostaglandins E1 and F2alpha on isolated intrapulmonary vascular smooth muscle. Proc Soc Exp Biol Med (1975) 0.90

Influence of inhibitors of prostaglandin synthesis on venoconstrictor responses to bradykinin. J Pharmacol Exp Ther (1976) 0.90

Oppositional effects of acetylcholine and isoproterenol on isometric tension and cyclic nucleotide concentrations in rabbit atria. J Cyclic Nucleotide Res (1975) 0.90

Effect of prostaglandins E 1 , E 2 and A 2 on vascular resistance and responses to noradrenaline, nerve stimulation and angiotensin in the dog hindlimb. Br J Pharmacol (1972) 0.90

Adenosine and ATP produce vasoconstriction in the feline pulmonary vascular bed by different mechanisms. J Pharmacol Exp Ther (1991) 0.90

Distribution of histamine in the canine autonomic nervous system. J Pharmacol Exp Ther (1970) 0.90

Regulation of arterial pressure lability in rats with chronic sinoaortic deafferentation. Am J Physiol (1987) 0.89

Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed. Eur J Pharmacol (2001) 0.89

Neural projections from paraventricular nucleus that subserve vasomotor functions. Am J Physiol (1985) 0.89

Evidence for existence of postjunctional alpha 1- and alpha 2-adrenoceptors in cat pulmonary vascular bed. Am J Physiol (1985) 0.89

Influence of prostaglandins E1 and F2a on pulmonary vascular resistance in the sheep. Proc Soc Exp Biol Med (1974) 0.89

N omega-nitro-L-arginine selectively inhibits vasodilator responses to acetylcholine and bradykinin in cats. Am J Physiol (1991) 0.89

Vasoconstrictor hyperresponsiveness: an early pathogenic mechanism in the spontaneously hypertensive rat. Eur J Pharmacol (1978) 0.89

Acetone odor and irritation thresholds obtained from acetone-exposed factory workers and from control (occupationally unexposed) subjects. Am Ind Hyg Assoc J (1997) 0.89

Hemodynamic effects of vasodilator agents in dogs with experimental ventricular septal defects. Circulation (1976) 0.89

Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats. Int J Impot Res (2004) 0.89

Pharmacotherapy for erectile dysfunction. Trends Pharmacol Sci (2000) 0.89

Chronic lesion of rostral ventrolateral medulla in spontaneously hypertensive rats. Hypertension (1992) 0.89

Role of central mineralocorticoid binding sites in development of hypertension. Am J Physiol (1990) 0.89

Determinants of renal vascular resistance in the Dahl strain of genetically hypertensive rat. Hypertension (1980) 0.88

Relaxation of bovine coronary arterial smooth muscle by cyclic GMP, cyclic AMP and analogs. J Pharmacol Exp Ther (1980) 0.88

Vascular tone influences arterial pressure lability after sinoaortic deafferentation. Am J Physiol (1991) 0.88

Arterial pressure lability and renal sympathetic nerve activity are dissociated in SAD rats. Am J Physiol (1992) 0.88

Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat. Am J Physiol (1997) 0.88

Characterization of the vasoconstrictor activity of indomethacin in the mesenteric vascular bed of the cat. Prostaglandins Leukot Med (1987) 0.88

The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit. Biochem Biophys Res Commun (1997) 0.88

Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat. Biol Reprod (2001) 0.88

Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed. J Pharmacol Exp Ther (1980) 0.88

Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids. Proc Natl Acad Sci U S A (1977) 0.88